Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lee Krug
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic
Scottsdale, Arizona, United States
- Arizona Cancer Center
Tucson, Arizona, United States
- City of Hope
Duarte, California, United States
- University of Chicago
Chicago, Illinois, United States
- Karmanos Cancer Institute/wayne State University
Detroit, Michigan, United States
- Nevada Cancer Institute
Las Vegas, Nevada, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Memorial-Sloan Kettering Cancer Center
New York, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Penn State Milton S. Hershey Medical Ctr.
Hershey, Pennsylvania, United States
- Cancer Therapy & Research Center
San Antonio, Texas, United States
- Huntsman Cancer Institute
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2008
- Primary completion
- 31 Jul 2012
- Completion
- 30 Nov 2012
- Last update posted
- 20 Jul 2021
- Registered enrollment
- 69
- Registry id
- NCT00700336
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.